ImmunologyCancer Immunology ResearchPeer-reviewed
PVRL2 Suppresses Anti-tumor Immunity Through PVRIG- and TIGIT-Independent Pathways
Jiuling Yang, Li Wang, James R. Byrnes…·Robert H. Blelloch
This study shows PVRL2 suppresses anti-tumor immunity independently of PVRIG and TIGIT, with deletion reducing tumor growth more than PD-L1 loss.
14 citations